Lymphoma Canada Awareness Day at Queen’s Park EventsNews Lymphoma Canada Awareness Day at Queen’s Park
New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients News New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients
New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients News New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients
Manitoba Leads the Way in CLL Research and Treatment News Manitoba Leads the Way in CLL Research and Treatment
Hodgkin Lymphoma Patient, Survivor & Caregiver Surveys News Hodgkin Lymphoma Patient, Survivor & Caregiver Surveys
CAR-T Cell Therapy Shows Promise in Aggressive NHL News CAR-T Cell Therapy Shows Promise in Aggressive NHL
Pembrolizumab may help those with relapsed NK-cell and T-cell lymphomas News Pembrolizumab may help those with relapsed NK-cell and T-cell lymphomas
Health Canada Approves GAZYVA® for Patients with Previously Treated Follicular Lymphoma NewsResearch Health Canada Approves GAZYVA® for Patients with Previously Treated Follicular Lymphoma